Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia

被引:18
|
作者
Procianoy, Renato S. [1 ,2 ]
Hentges, Claudia R. [1 ,2 ]
Silveira, Rita C. [1 ,2 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Pediat, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Newborn Sect, Porto Alegre, RS, Brazil
关键词
preterm neonates; VEGF/PIGF heterodimer; angiogenesis; respiratory distress syndrome; bronchopulmonary dysplasia; CHRONIC LUNG-DISEASE; PREMATURE-INFANTS; ANGIOGENESIS; VEGF; ASTHMA; PREECLAMPSIA; RECEPTOR-1; EXPRESSION; DISCOVERY;
D O I
10.1055/s-0035-1566294
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Bronchopulmonary dysplasia (BPD) is associated with changes in pulmonary angiogenesis. However, the role of the vascular endothelial growth factor/placental growth factor (VEGF/PIGF) heterodimer, an antiangiogenic factor, remains unknown in this disease. Objective To compare VEGF/PIGF levels in preterm infants with and without BPD. Methods This study was approved by the Institutional Review Board. Preterm neonates with birth weight <2,000 g and gestational age <= 34 weeks were included. Exclusion criteria were: neonates transferred from other institutions after 72 hours of life; death before blood collection; presence of major congenital malformations, inborn errors of metabolism, and early sepsis; and mothers with multiple pregnancies, TORCH infections, HIV infection, or autoimmune diseases. BPD was defined as the need for oxygen therapy for a period equal to or greater than 28 days, accompanied by radiographic changes compatible with the disease. Blood was collected from neonates in the first 72 hours of life. VEGF/PIGF levels were measured using the enzyme-linked immunosorbent assay method. The chi-square test, t-test, Mann Whitney test, analysis of variance, and Kruskal Wallis test were used for statistical analysis. Variables found to be significant in the univariate analysis were included in the multivariate analysis. Results Seventy-three patients were included (19 with BPD, 43 without BPD, and 11 neonates who died in the first 28 days of life), with a mean (SD) gestational age of 30.32 (2.88) weeks and birth weight of 1,288 (462) g. Median VEGF/PIGF levels were higher in the groups with BPD and death in the first 28 days of life than in the group without BPD (16.46 [IQR, 12.19-44.57] and 20.64 [IQR, 13.39-50.22], respectively, vs. 9.14 [IQR, 0.02-20.64] pg/mL], p < 0.001). Higher VEGF/P1GF levels remained associated with BPD and death in the first 28 days of life in the multivariate analysis. Conclusion Higher plasma VEGF/PIGF levels were found in preterm neonates with BPD and in those who died in the first 28 days of life, suggesting an important role of this substance in pulmonary vascular development.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 50 条
  • [1] Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants
    Mariduena, Joseph
    Ramagopal, Maya
    Hiatt, Mark
    Chandra, Shakuntala
    Laumbach, Robert
    Hegyi, Thomas
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (08): : 1517 - 1522
  • [2] Treatment of bronchopulmonary dysplasia by vascular endothelial growth factor: the earlier the better?
    Luo, Jinghua
    Si, Yingjian
    Chen, Jia
    Feng, Zhichun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (02): : 474 - 487
  • [3] Glucocorticoids in preterm infants and discrepancies of vascular endothelial growth factor
    Vento, G
    Matassa, PG
    Capoluongo, E
    Tortorolo, L
    Romagnoli, C
    Ameglio, F
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (04) : 501 - 501
  • [4] Vascular Endothelial Growth Factor as Molecular Target for Bronchopulmonary Dysplasia Prevention in Very Low Birth Weight Infants
    Perrone, Serafina
    Manti, Sara
    Buttarelli, Luca
    Petrolini, Chiara
    Boscarino, Giovanni
    Filonzi, Laura
    Gitto, Eloisa
    Esposito, Susanna Maria Roberta
    Nonnis Marzano, Francesco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [5] Vascular endothelial growth factor in preterm infants with respiratory distress syndrome
    Tsao, PN
    Wei, SC
    Chou, HC
    Su, YN
    Chen, CY
    Hsieh, FJ
    Hsieh, WS
    PEDIATRIC PULMONOLOGY, 2005, 39 (05) : 461 - 465
  • [6] Low Urine Vascular Endothelial Growth Factor Levels Are Associated with Mechanical Ventilation, Bronchopulmonary Dysplasia and Retinopathy of Prematurity
    Levesque, Bernadette M.
    Kalish, Leslie A.
    Winston, Abigail B.
    Parad, Richard B.
    Hernandez-Diaz, Sonia
    Phillips, Michele
    Zolit, Amy
    Morey, JoAnn
    Gupta, Munish
    Mammoto, Akiko
    Ingber, Donald E.
    Van Marter, Linda J.
    NEONATOLOGY, 2013, 104 (01) : 56 - 64
  • [7] The effect of placental growth factor and vascular endothelial growth factor on endothelial hydraulic conductivity.
    Yuan, J
    Dull, RO
    Chang, YS
    Tarbell, J
    Jain, RK
    Munn, LL
    FASEB JOURNAL, 2000, 14 (04): : A21 - A21
  • [8] Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia
    Gannoun, Marwa Ben Ali
    Bourrelly, Severine
    Raguema, Nozha
    Zitouni, Hedia
    Nouvellon, Eva
    Maleh, Wided
    Chemili, Afraa Brahim
    Elfeleh, Raja
    Almawi, Wassim
    Mahjoub, Touhami
    Gris, Jean-Christophe
    CYTOKINE, 2016, 79 : 1 - 6
  • [9] Consecutive serum vascular endothelial growth factor levels in premature infants
    Asami, Tetsu
    Nonobe, Norie
    Kaneko, Hiroki
    Futamura, Yukiko
    Kimoto, Reona
    Hirakawa, Akihiro
    Sato, Yoshiaki
    Hayakawa, Masahiro
    Terasaki, Hiroko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [10] Regional variation in placental expression of vascular endothelial growth factor a and placental growth factor in normal pregnancies
    Mundy, David
    De, Alok
    Heitmann, Erica
    Maulik, Dev
    Maulik, Devika
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S87 - S88